|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
1.800 0.000 (0.000%) | 2025/12 - Final HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | (16,985) | 1,235 | 37,788 | 13,005 | (4,896) |
| Net Cash from / (used in) Investing Activities | 15,379 | (2,096) | (8,172) | 7,928 | (39,814) |
| Net Cash from / (used in) Financing Activities | (3,473) | (15,699) | (22,830) | (13,965) | 43,241 |
| Increase / (Decrease) in Cash & Cash Equivalents | (5,079) | (16,560) | 6,786 | 6,968 | (1,469) |
| Cash & Cash Equivalents at beginning of period | 22,999 | 40,002 | 33,649 | 26,743 | 28,208 |
| Effect of Foreign Exchange Rate Changes | 0 | 0 | (433) | (62) | 4 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 17,920 | 23,442 | 40,002 | 33,649 | 26,743 |
| Remarks: | Real time quote last updated: 30/04/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 13,350 |
| %Change | -- |
| EPS / (LPS) | HKD 0.050 |
| NBV Per Share ($) | HKD -0.224 |